Publication | Closed Access

Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineBrain DiseaseNeurochemical BiomarkersNeuroprotectionNeurologyNeuroscienceNeurodegenerationBrain PathologyPharmacologyContinual Enzyme DeliveryMouse Model